The present invention relates to a wearable thorax percussion device.
Cystic fibrosis (CF) is a hereditary chronic disease affecting human patients that causes the buildup of thick, sticky mucous in the lungs and other parts of the body. If left untreated, the mucous can clog air ways, and lead to complications such as tissue inflammation or infection, or other symptoms such as coughing, phlegm, and compromised cardio-respiratory performance.
One technique to manage CF is chest physiotherapy (CPT) which involves the manipulation of the patient's thorax to dislodge mucous buildup in the airways and encourage expectoration of the mucous. CPT may have to be performed in several sessions in a day, with each session lasting from between 10 to 45 minutes. CPT can be performed manually by therapists who use their hands to repeatedly percuss (clap, thump or press against) the patient's thorax. However, manually performed CPT can be physically and time demanding and should be performed by a properly trained therapist. Alternatively, CPT can be performed using handheld or wearable mechanical devices. Wearable devices have the advantage over handheld devices of relieving the therapist or patient from having to manipulate the device during the treatment session.
Some wearable devices administer pulsating pneumatic pressure to the patient. U.S. Pat. No. 4,838,263 to Warwick et al, describes a vest bladder containing an air chamber and a pressurizing means to alternately pressurize and depressurize the air chamber to produce a pulsating compression on the patient's thorax. U.S. Pat. No. 6,036,662 to Van Brunt et al. describes a vest containing an air bladder that coverts pulses of air into compressions to the patient's thorax. US Pat. Application No. 2005/0234372 to Hansen et al. describes a vest with an internal air chamber for receiving repeated pulses of air, which translate through the vest as pressure pulses against the patient's thorax. However, these devices rely on intimate contact between the vest and the patient's thorax and tend act over a relatively large area of the patient's thorax, with the result that they may constrict the patient's normal breathing motions.
Some wearable devices sonically transmit pressure waves to the patient generated by an acoustic transducer. U.S. Pat. No. 6,193,677 to Cady describes a vest incorporating a speaker to deliver low frequency pulsed audio signals to the patient. U.S. Pat. No. 6,193,677 to Plante describes a vest with a plurality of pockets or a harness-type arrangement to support an acoustic transducer to propagate acoustic waves via an acoustic coupling chamber to the patient. US Pat. Application No. 2008/0108914 to Brouqueyre et al. describes a vest with a vibration unit to transmit low frequency acoustic waves through a form-fitting material like a gel or fluid contained in the inner surface of the vest. However, transmission of pressure waves through a compressible medium may not be as efficacious as direct mechanical manipulation of the patient's thorax.
Some wearable devices administer mechanical impacts or vibrations to the patient. U.S. Pat. No. 3,310,050 to Goldfarb describes a vest-like garment or harness-type arrangement with a plurality of pockets to support a plurality of electro-mechanical vibrators to produce pulsating impacts that are communicated to the patient either by direct contact with the patient or indirectly through coupling constituted by the vest material and webbing belts. U.S. Pat. No. 5,235,967 to Arbisi et al. describes a vest-like garment with an internalized frame continuous throughout the garment, containing a plurality of movable electrically conductive elements that are actuated by a pulsed magnetic field produced by drive coils that are energized by a drive circuit. U.S. Pat. No. 5,261,394 to Mulligan et al. describes a percussive aid comprising arms that are reciprocally driven between a cocked position and a contact position by a drive mechanism, within a frame curved to fit the patient and adapted to be worn like a backpack, secured to the patient's thorax by shoulder and waist straps. US Pat. Appl. No. 2006/0089575 to DeVlieger describes a rigid element with pads clamped to the body, which transmit vibrations from an attached vibrator. The effectiveness of such devices depends on the ability to maintain contact at the interface between the device and the patient.
Accordingly, there remains a need for a wearable thorax percussion device that provides for effective, comfortable, convenient and consistent treatment of the patient.
In one aspect, the present invention provides a wearable thorax percussion device comprising:
In another aspect, the invention may comprise a wearable thorax percussion device comprising at least one electromechanical actuator, which comprises:
Embodiments of the device provides a mechanical means for CPT without the labour of a trained therapist. The device may be embodied in a form that is light weight, and ergonomically adapted to the anatomy of the thoracic region. The attachment of the rigid elements to the external surface of the garment permits the device to readily be adjusted for thoraxes of different dimensions. In one embodiment, the use of a rigid element to preload compressible actuators assists in maintaining positive contact between the device and the thorax.
In the drawings, like elements are assigned like reference numerals. The drawings are not necessarily to scale, with the emphasis instead placed upon the principles of the present invention. Additionally, each of the embodiments depicted are but one of a number of possible arrangements utilizing the fundamental concepts of the present invention. The drawings are briefly described as follows:
The invention relates to a wearable thorax percussion device 10. When describing the present invention, all terms not defined herein have their common art-recognized meanings.
The term “thorax” as used herein means the region of the human body including the thoracic cavity enclosing the lungs, trachea and bronchi or portions thereof.
As shown in
In one embodiment, as shown in
In one embodiment, the device comprises a front right rigid element (30a), a front left rigid element (30b) and a single rear rigid element (30b) attached to the front right portion, front left portion, rear portion, respectively, of the exterior surface (21) of the garment (20). This configuration of rigid elements (30) accommodates a garment having a front central closure, such as a full length zipper. The rigid elements may be substantially rigid or semi-rigid. It is not essential that these elements be completely inflexible, but they do have to have enough strength to allow transmission of the percussive force of the actuators to the patient's body, instead of dissipating outwards. Some flexibility may be desired to allow for differences in individual patient sizes and shapes.
The front rigid elements (30a, 30b) may have a bow-shape to avoid resting on the patient's breasts, which might prevent the retained actuators (40a to 40d) from positively contacting the thorax. The rigid elements (30) may be configured with cavities, fingers, apertures and other features to retain or permit access to the actuators (40) and the controller (60). In addition to retaining the actuators (40), the rigid elements (30) protect the actuators (40) from “stalling out” if, for example, the patient were to bear weight on the actuators (40) against a chair back while wearing the device. The rigid elements (30) may be manufactured from materials that are light weight, and have sufficient stiffness, impact resistance and durability to retain the actuators (40) with repeated use. Suitable plastics may be used with techniques such as vacuum forming, machining with computer numerical control (CNC), compression molding, reaction-injection molding, injection molding or a combination of the foregoing. Suitable varieties of plastics include ABS (acrylonitrile-butadienestyrene), polystyrene, high impact polystyrene (HIPS), and KYDEX™. The rigid elements (30) are visible on the exterior of the garment and include at least two cavities defined by arcuate walls for receipt of the cylindrically shaped outer surfaces of the actuator housings (50).
In one embodiment, as shown in
In one embodiment, each front rigid element (30a, 30b) retains two actuators (40a to 40c) to percuss the front region of the thorax to the right and left of the sternum. The rear rigid element (30c) retains four actuators (40e to 40h) to percuss the user's back, symmetrically about the spine. The number of actuators (40) and their positioning can be strategically selected. In general, the position of the actuators (40) relative to the sternum and the spine should preferably not change significantly with patients ranging from the 5th percentile to the 95th percentile, and as such a single size of rigid element (30) with adjustable placement of actuators can be used by a large portion of the patient demographic.
In one embodiment, the actuator comprises a cap (41) at one end to provide an interface to percuss the thorax, and a housing (50) at the other end to attach to the rigid element (30) with a suitable attachment means, such as a screw (51). A permanent magnet (49) creates a magnetic field that permeates through the surrounding housing (50) and inner disc (48), which are made of non-permanent magnetic materials and separated by a magnetic gap (52). A wire coil (47) wrapped around a bobbin (46) creates an electromagnet. When an electric current is passed through the wire coil (47), it produces a magnetic field opposite in direction to the magnetic field created by the permanent magnet (49). The interaction of the magnetic fields forces the bobbin (46) and the attached cap (41) against the thorax, thereby causing the chest wall to oscillate. The actuator (41) should be constructed to withstand repetitive use and heat. The bobbin (46) and cap (41) have channels (46a, 41a) through which the wire coil (47) can exit the actuator (40) without a stress point. The bobbin (46) may be constructed of a wear and temperature resistant material such as PPS (polyphenylene sulphide), ULTEM™ polymer, or polysulfone thermoplastic polymers. The bobbin may also acts as the bearing surface in the event that there are side loading forces. The wire coil (47) may be constructed with multi-strand wires or wires covered by a silicone sheath. Wire gauges ranging between 22 g and 30 g are appropriate for this application. In one embodiment, the wire coil (47) comprises 6 layers of 28 g wiring.
In one embodiment, the actuator (40) is compressible between the thorax and the rigid element (30). Thus, the rigid element (30) can “preload” the actuator (40) by pressing it against the thorax to better maintain positive contact between the cap (41) and the thorax. The actuator (40) is made compressible by springs (45) or other resilient compressible means. The springs (45) pass through apertures in the bobbin (46) and inner disc (48), connected at one end to the cap (41) using a washer (42) and bear at the other end on the magnet (49). An assembly of screws (43) and D-washers (44) retains the springs (45) to the inner disc (48). As shown in
One embodiment of the electronic controller (60), as shown in
In one embodiment, the controller (60) may include a variety of controls such as an on/off control to start or stop a prescribed treatment cycle, a pause control to temporarily stop the treatment cycle to allow for mucous clearance, a frequency control to adjust the rate at which the actuators (40) deliver percussive force, an amplitude control to adjust the amount of current applied to the actuators (40) in a given period, and a timer for the on/off functionality to ensure that the treatment cycle is completed while accounting for any pauses.
The rigid elements (30), actuators (40) and the controller (60) may be tuned to produce desired force specifications. In one embodiment, the actuators (40) have a force constant of approximately 1 to 30 lbs per Ampere and apply percussive forces to the thorax of approximately 5 lbs, and within a reasonable range of 1 to 10 lbs, which is similar to the magnitude of forces applied by a therapist administering manual CPT. The actuator (40) comprises three springs having a spring rate of 10 lbs per inch and the actuators (40) are “preloaded” to apply a force of approximately 1 lb, within a reasonable range of 0 to 5 lbs.
Number | Name | Date | Kind |
---|---|---|---|
1646590 | Mildenberg | Oct 1927 | A |
2486667 | Meister | Nov 1949 | A |
3053250 | Stubbs | Sep 1962 | A |
3291123 | Terauchi | Dec 1966 | A |
3310050 | Goldfarb | Mar 1967 | A |
3460531 | Gardner | Aug 1969 | A |
3802417 | Lang | Apr 1974 | A |
3955563 | Maione | May 1976 | A |
4069816 | Yamamura et al. | Jan 1978 | A |
4079733 | Denton et al. | Mar 1978 | A |
4098266 | Muchisky et al. | Jul 1978 | A |
4102334 | Muchisky | Jul 1978 | A |
4216766 | Duykers et al. | Aug 1980 | A |
4387708 | Davis | Jun 1983 | A |
4397306 | Weisfeldt et al. | Aug 1983 | A |
4453538 | Whitney | Jun 1984 | A |
4508107 | Strom et al. | Apr 1985 | A |
4512339 | McShirley | Apr 1985 | A |
4530349 | Metzger | Jul 1985 | A |
4624244 | Taheri | Nov 1986 | A |
4697580 | Terauchi | Oct 1987 | A |
4838263 | Warwick et al. | Jun 1989 | A |
4887594 | Siegel | Dec 1989 | A |
4977889 | Budd | Dec 1990 | A |
5018517 | Liardet | May 1991 | A |
5056505 | Warwick et al. | Oct 1991 | A |
5167226 | Laroche et al. | Dec 1992 | A |
5181504 | Ono et al. | Jan 1993 | A |
5235967 | Arbisi et al. | Aug 1993 | A |
5261394 | Mulligan et al. | Nov 1993 | A |
5334131 | Omandam et al. | Aug 1994 | A |
5451190 | Liardet | Sep 1995 | A |
5453081 | Hansen | Sep 1995 | A |
5455159 | Mulshine et al. | Oct 1995 | A |
5496262 | Johnson, Jr. et al. | Mar 1996 | A |
5569170 | Hansen | Oct 1996 | A |
5716131 | Breeding | Feb 1998 | A |
5738637 | Kelly et al. | Apr 1998 | A |
5769797 | Van Brunt et al. | Jun 1998 | A |
5769800 | Gelfand et al. | Jun 1998 | A |
5891062 | Schock et al. | Apr 1999 | A |
6022328 | Hailey | Feb 2000 | A |
6036662 | Van Brunt et al. | Mar 2000 | A |
6098222 | Hand et al. | Aug 2000 | A |
6174295 | Cantrell et al. | Jan 2001 | B1 |
6176235 | Benarrouch et al. | Jan 2001 | B1 |
6190337 | Nedwell | Feb 2001 | B1 |
6193677 | Cady | Feb 2001 | B1 |
6193678 | Brannon | Feb 2001 | B1 |
6254556 | Hansen et al. | Jul 2001 | B1 |
6290660 | Epps et al. | Sep 2001 | B1 |
6352518 | nee Wolf | Mar 2002 | B1 |
D456591 | Hansen | May 2002 | S |
D461897 | Hansen et al. | Aug 2002 | S |
6478755 | Young | Nov 2002 | B2 |
D469876 | Hansen et al. | Feb 2003 | S |
6547749 | Hansen | Apr 2003 | B2 |
D478989 | Hansen et al. | Aug 2003 | S |
6676614 | Hansen et al. | Jan 2004 | B1 |
6702769 | Fowler-Hawkins | Mar 2004 | B1 |
6736785 | Van Brunt | May 2004 | B1 |
6958047 | DeVlieger | Oct 2005 | B2 |
6984214 | Fowler-Hawkins | Jan 2006 | B2 |
7074200 | Lewis | Jul 2006 | B1 |
7128811 | Watanabe | Oct 2006 | B2 |
D531728 | Helgeson | Nov 2006 | S |
7207953 | Goicaj | Apr 2007 | B1 |
7232417 | Plante | Jun 2007 | B2 |
D547718 | Helgeson et al. | Jul 2007 | S |
7278978 | Hansen et al. | Oct 2007 | B1 |
7343916 | Biondo et al. | Mar 2008 | B2 |
7374550 | Hansen et al. | May 2008 | B2 |
7416536 | DeVlieger | Aug 2008 | B2 |
7445607 | Plante | Nov 2008 | B2 |
D585991 | Helgeson et al. | Feb 2009 | S |
7537575 | Hansen et al. | May 2009 | B2 |
7597670 | Warwick et al. | Oct 2009 | B2 |
7618384 | Nardi et al. | Nov 2009 | B2 |
7713219 | Helgeson et al. | May 2010 | B2 |
7736324 | Helgeson | Jun 2010 | B1 |
7762967 | Warwick et al. | Jul 2010 | B2 |
7785280 | Kivisto | Aug 2010 | B2 |
7798982 | Zets | Sep 2010 | B2 |
7927293 | Ignagni et al. | Apr 2011 | B1 |
7931607 | Biondo et al. | Apr 2011 | B2 |
D639954 | Helgeson et al. | Jun 2011 | S |
7981066 | Lewis | Jul 2011 | B2 |
8108957 | Richards et al. | Feb 2012 | B2 |
8192381 | Nozzarella | Jun 2012 | B2 |
8197428 | Helgeson et al. | Jun 2012 | B2 |
8202237 | Helgeson et al. | Jun 2012 | B2 |
8241233 | Litton et al. | Aug 2012 | B2 |
8257288 | Hansen et al. | Sep 2012 | B2 |
8273039 | Ignagni | Sep 2012 | B1 |
8460223 | Huster et al. | Jun 2013 | B2 |
8584279 | Richards et al. | Nov 2013 | B2 |
D697197 | Hansen et al. | Jan 2014 | S |
8734370 | Ignagni | May 2014 | B1 |
8777880 | Davis et al. | Jul 2014 | B2 |
8790285 | Bisera et al. | Jul 2014 | B2 |
8801643 | Deshpande et al. | Aug 2014 | B2 |
20020014235 | Rogers et al. | Feb 2002 | A1 |
20020016560 | Hansen | Feb 2002 | A1 |
20020111571 | Warwick et al. | Aug 2002 | A1 |
20020195144 | Hand et al. | Dec 2002 | A1 |
20040069304 | Jam | Apr 2004 | A1 |
20040097842 | Van Brunt et al. | May 2004 | A1 |
20040097843 | Van Brunt et al. | May 2004 | A1 |
20040097844 | Van Brunt et al. | May 2004 | A1 |
20040097845 | Van Brunt | May 2004 | A1 |
20040097846 | Van Brunt et al. | May 2004 | A1 |
20040097847 | Van Brunt et al. | May 2004 | A1 |
20040097849 | Van Brunt | May 2004 | A1 |
20040097850 | Plante | May 2004 | A1 |
20040158177 | Van Brunt et al. | Aug 2004 | A1 |
20050234372 | Hansen et al. | Oct 2005 | A1 |
20060015045 | Zets et al. | Jan 2006 | A1 |
20060089575 | DeVlieger | Apr 2006 | A1 |
20070239087 | Kivisto | Oct 2007 | A1 |
20080108914 | Brouqueyre et al. | May 2008 | A1 |
20080300515 | Nozzarella et al. | Dec 2008 | A1 |
20090069728 | Hoffmann et al. | Mar 2009 | A1 |
20090221944 | Hobson | Sep 2009 | A1 |
20090255022 | Smith et al. | Oct 2009 | A1 |
20100113993 | Davis et al. | May 2010 | A1 |
20100242955 | Hansen | Sep 2010 | A1 |
20100249634 | Hansen | Sep 2010 | A1 |
20110125068 | Hansen et al. | May 2011 | A1 |
20110166486 | Kumanomido | Jul 2011 | A1 |
20120259255 | Tomlinson et al. | Oct 2012 | A1 |
20120291798 | Park et al. | Nov 2012 | A1 |
20130261518 | Hansen et al. | Oct 2013 | A1 |
20130331747 | Helgeson et al. | Dec 2013 | A1 |
Number | Date | Country |
---|---|---|
2563723 | Aug 2011 | CA |
1136896 | Dec 1968 | GB |
2 068 737 | Feb 1981 | GB |
2011094883 | Aug 2011 | WO |
Entry |
---|
Rubin, Bruce K.; Emerging Therapies for Cystic Fibrosis Lung Disease; Chest; 1999; vol. 115; pp. 1120-1126. |
International Biophysics Corporation—“AffloVest Answering Needs: The Role of the AffloVest in the Respiratory Market” AffloVest White Paper. |
The “VibraVest” by OxyCare GmbH, VibraVest—engl—web.pdf, Nov. 23, 2011 (3 pages). |
Number | Date | Country | |
---|---|---|---|
20140005579 A1 | Jan 2014 | US |